Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
CA 2173460 A1 · Owner: Rousselle, Jean-Claude · Inventors: Massot, Olivier; Rousselle, Jean-Claude; Fillion, Gilles
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds having the following peptide sequence: X Leu Y wherein X is H or Ala or Leu-Ser-Ala, Y is OH or peptide sequence having from 1 to 10 amino acids with the terminal carboxy end being amidified by a NH¿2? group or esterified by a substituted or non-substituted hydrocarbyloxy with the proviso that X and Y are not simultaneously H and OH respectively, The invention also concerns the corresponding compounds wherein the peptide binding group -CO-NH- is replaced by a binding group resisting protease enzymatic degradation or wherein the peptide backbone comprises one or more intercalated groups making the peptide binding resistant to enzymatic degradation. Also described are compounds …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 4, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 4, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 4, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.